Published data demonstrate that mTOR is essential for pulmonary vascular remodeling and occlusive intimal lesions, which suggests mTORC1/2 complexes, Raptor and Rictor, may both contribute to the development and progression of PAH. This evidence concerns the gene RPTOR and pulmonary arterial hypertension.